Bilateral Ventriculomegaly at 33 Weeks Gestation

Definition and Classification

Ultrasound Appearance

Epidemiology

• Overall incidence: 1-2 per 1,000 births
• Mild VM: 1.4/1,000 (low-risk) to 22/1,000 (high-risk populations)
• Males are more commonly affected than females (especially idiopathic mild VM >20 weeks)
• Aqueductal stenosis is the most common single cause, accounting for 30-40% of cases

Differential Diagnosis (Causes of Bilateral VM)

• Aqueductal stenosis (most common cause overall; typically severe bilateral VM with dilated 3rd ventricle, normal posterior fossa)
• Chiari II malformation (associated with open spina bifida)
• Dandy-Walker malformation
• Tumor/mass effect

• Agenesis of the corpus callosum (classic: teardrop-shaped dilated atria / colpocephaly; absent CSP)
• Septo-optic dysplasia
• Holoprosencephaly
• Schizencephaly
• Cortical dysplasias (lissencephaly, pachygyria, polymicrogyria, gray matter heterotopia)

• Trisomy 21, 18, 13 (~11% of mild-moderate VM cases)
• X-linked hydrocephaly (L1CAM/LICAM mutation at Xq28 - seen in ~1:30,000 males; associated with bilateral abducted thumbs)
• MASA syndrome

• CMV, toxoplasmosis, Zika virus (look for periventricular calcifications)
• Intracranial hemorrhage / hypoxic-ischemic injury (especially in monochorionic twins after co-twin demise)
• Porencephaly / encephalomalacia

• Diagnosis of exclusion; more common in males at >20 weeks

Why 33 Weeks is Significant

1. New-onset VM may be progressive - Hypoxic-ischemic injury and hemorrhage often present with mild VM that becomes progressive with advancing gestation. Serial measurements are mandatory.
2. MRI advantage: Third-trimester MRI has superior diagnostic performance for cortical, white matter, and hemorrhagic abnormalities compared to earlier imaging. It is not limited by bony skull artifact and clearly differentiates lethal hydranencephaly from shuntable severe hydrocephalus.
3. Congenital VM may develop late - a normal mid-trimester scan does not exclude this condition.
4. Delivery planning is imminent - neonatal neurosurgical coordination must begin.

Investigations (Antenatal Workup)

1. Detailed anatomic survey - assess for associated structural anomalies
2. Fetal neurosonography - dedicated brain scan; transvaginal approach if vertex in pelvis
3. Fetal echocardiogram - cardiac defects common with aneuploidy
4. Fetal MRI - strongly recommended; the SMFM recommends consideration of MRI to detect additional CNS anomalies missed on ultrasound. A 2019 meta-analysis confirmed MRI adds value even after dedicated neurosonography (particularly third-trimester MRI for cortical/white matter/hemorrhagic lesions)
5. Genetic counseling + amniocentesis:
   • Chromosomal microarray (karyotype alone insufficient)
   • If X-linked hydrocephaly suspected: LICAM gene mutation at Xq28
   • Aneuploidy rate ~3% in isolated mild VM; ~11% in mild-moderate VM with other anomalies
6. Infection workup (amniotic fluid PCR):
   • CMV
   • Toxoplasmosis
   • Zika virus (if relevant exposure history)
7. Serial ultrasound - monitor progression of ventricular size

Obstetric Management

• Delivery mode: In the absence of macrocephaly, trial of labor is indicated in vertex presentation. Vaginal delivery is not contraindicated in mild VM.
• Cesarean section reserved for standard obstetric indications.
• Each case must be individualized, especially when associated malformations are present.
• Cephalocentesis for cephalopelvic disproportion is controversial - may worsen neurologic prognosis.

Neonatal Management

• Evaluation by neonatology + pediatric neurology + neurosurgery (for moderate/severe VM)
• Repeat head ultrasound and/or MRI postnatally to reassess
• Serial head circumference measurements
• Surgical management (e.g., ventriculo-peritoneal shunt or endoscopic third ventriculostomy) for progressive VM
• Chromosomal microarray if neonate appears dysmorphic and prenatal studies not done

Prognosis

• Isolated vs. associated: Associated structural/chromosomal/infectious causes carry much worse prognosis
• Progression: Progressive VM (increasing atrial width on serial scans) is a poor prognostic sign
• Cortical mantle thickness: Thin cortex on MRI worsens neurodevelopmental outlook
• Severity: Moderate-severe bilateral VM warrants guarded prognosis and full multidisciplinary counseling

Summary Algorithm at 33 Weeks

Bilateral VM identified on U/S at 33 weeks
        ↓
Measure atrial width (mild/moderate/severe?)
        ↓
Detailed neurosonography + fetal echo
        ↓
Fetal MRI (especially for cortical/white matter assessment)
        ↓
Amniocentesis: microarray + CMV/Toxo PCR
(+/- LICAM if male + abducted thumbs)
        ↓
Serial U/S q2-4 weeks to assess progression
        ↓
Multidisciplinary counseling (MFM, genetics, pediatric neurology, neurosurgery)
        ↓
Delivery planning: vaginal if no macrocephaly; neonatal team present
        ↓
Postnatal: head U/S / MRI + neurosurgery referral if progressive